Annual EBITDA
$1.56B$270.93M+20.96%
Summary
- Current Value
- As of today, RPRX annual EBITDA is $1.56B, up +20.96% on
- Historical Performance
- RPRX annual EBITDA is up +68.36% over the past 3 years, down -3.40% over the past 5 years
- All-Time High Comparison
- RPRX annual EBITDA is currently -40.94% below its historical high of $2.65B set on
- 3-Year Low Comparison
- RPRX annual EBITDA is +68.36% above its 3-year low of $928.56M reached on an earlier date
- Sector Comparison
- RPRX annual EBITDA is higher than 94.66% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.56B | +21.0% | +68.4% | -3.4% | +81.3% | |
| Quarterly EBITDA | $633.65M | +18.6% | +32.3% | +169.7% | +44.8% | |
| TTM EBITDA | $1.66B | -12.6% | +40.5% | +11.8% | +279.7% | |
| Price | $54.50 | +68.7% | +63.3% | +33.9% | – | |
| PE Ratio | 28.54 | +105.0% | -35.2% | +83.2% | – | |
| Annual Revenue | $2.38B | +5.1% | +6.3% | +12.1% | +43.9% | |
| Annual EPS | $1.78 | -6.8% | +1721.5% | -31.4% | +86.0% | |
| $1.56B | +20.7% | +69.0% | -2.3% | +96.3% | ||
| Annual Net Income | $1.32B | -0.5% | +475.6% | -22.2% | +74.5% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.56B | at high | |
| 5Y | $1.62B | N/A | -3.4% |
| All | $2.65B | -40.9% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $928.56M | N/A | +68.4% |
| 5Y | $928.56M | +68.4% | |
| All | $791.08M | +97.6% |
EBITDA History
FAQ
What is the current annual EBITDA of RPRX?
As of today, RPRX annual EBITDA is $1.56B
What is 1-year change in RPRX annual EBITDA?
RPRX annual EBITDA is up +20.96% year-over-year
What is 3-year change in RPRX annual EBITDA?
RPRX annual EBITDA is up +68.36% over the past 3 years
How far is RPRX annual EBITDA from its all-time high?
RPRX annual EBITDA is currently -40.94% below its historical high of $2.65B set on December 31, 2019
How does RPRX annual EBITDA rank versus sector peers?
RPRX annual EBITDA is higher than 94.66% of companies in Healthcare sector
When is RPRX next annual earnings release?
As of today, the next annual earnings release for RPRX has not been scheduled
Quarterly EBITDA
$633.65M$244.46M+62.81%
Summary
- Current Value
- As of today, RPRX quarterly EBITDA is $633.65M, up +62.81% on
- Historical Performance
- RPRX quarterly EBITDA is up +18.62% year-over-year, up +32.29% over the past 3 years
- All-Time High Comparison
- RPRX quarterly EBITDA is currently -52.63% below its historical high of $1.34B set on
- 3-Year Low Comparison
- RPRX quarterly EBITDA is +958.91% above its 3-year low of -$73.77M reached on
- Sector Comparison
- RPRX quarterly EBITDA is higher than 95.56% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $633.65M | +62.8% | +18.6% | +32.3% | +169.7% | |
| Annual EBITDA | $1.56B | – | +21.0% | +68.4% | -3.4% | |
| TTM EBITDA | $1.66B | +6.4% | -12.6% | +40.5% | +11.8% | |
| Price | $54.50 | +20.8% | +68.7% | +63.3% | +33.9% | |
| PE Ratio | 28.54 | +4.3% | +105.0% | -35.2% | +83.2% | |
| Quarterly Revenue | $630.58M | +1.4% | +11.0% | -7.8% | +10.0% | |
| Quarterly EPS | $0.67 | +35.0% | +62.8% | -11.9% | +280.0% | |
| $632.48M | +63.0% | +18.4% | +32.0% | +175.8% | ||
| Quarterly Net Income | $468.26M | +31.5% | +7.8% | -8.0% | +194.5% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $633.65M | at high | |
| 3Y | $735.07M | -13.8% | |
| 5Y | $750.68M | -15.6% | |
| All | $1.34B | -52.6% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $209.80M | +202.0% | |
| 3Y | -$73.77M | +958.9% | |
| 5Y | -$73.77M | +958.9% | |
| All | -$73.77M | +958.9% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of RPRX?
As of today, RPRX quarterly EBITDA is $633.65M
What is RPRX quarterly EBITDA most recent change?
RPRX quarterly EBITDA was up +62.81% on March 31, 2026
What is 1-year change in RPRX quarterly EBITDA?
RPRX quarterly EBITDA is up +18.62% year-over-year
How far is RPRX quarterly EBITDA from its all-time high?
RPRX quarterly EBITDA is currently -52.63% below its historical high of $1.34B set on December 31, 2019
How does RPRX quarterly EBITDA rank versus sector peers?
RPRX quarterly EBITDA is higher than 95.56% of companies in Healthcare sector
When is RPRX next earnings release?
The next earnings release for RPRX is on
TTM EBITDA
$1.66B$99.47M+6.37%
Summary
- Current Value
- As of today, RPRX TTM EBITDA is $1.66B, up +6.37% on
- Historical Performance
- RPRX TTM EBITDA is down -12.57% year-over-year, up +40.53% over the past 3 years
- All-Time High Comparison
- RPRX TTM EBITDA is currently -37.51% below its historical high of $2.66B set on
- 3-Year Low Comparison
- RPRX TTM EBITDA is +76.80% above its 3-year low of $939.51M reached on
- Sector Comparison
- RPRX TTM EBITDA is higher than 95.01% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.66B | +6.4% | -12.6% | +40.5% | +11.8% | |
| Annual EBITDA | $1.56B | – | +21.0% | +68.4% | -3.4% | |
| Quarterly EBITDA | $633.65M | +62.8% | +18.6% | +32.3% | +169.7% | |
| Price | $54.50 | +20.8% | +68.7% | +63.3% | +33.9% | |
| PE Ratio | 28.54 | +4.3% | +105.0% | -35.2% | +83.2% | |
| TTM Revenue | $2.44B | +2.6% | +7.8% | +3.4% | +11.2% | |
| TTM EPS | $1.91 | +15.8% | -17.7% | +151.8% | -26.9% | |
| $1.66B | +6.3% | -12.8% | +40.2% | +13.3% | ||
| TTM Net Income | $1.36B | +2.5% | -23.2% | +122.4% | -22.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.90B | N/A | -12.6% |
| 3Y | $1.90B | -12.6% | |
| 5Y | $1.90B | -12.6% | |
| All | $2.66B | -37.5% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.53B | +8.3% | |
| 3Y | $939.51M | +76.8% | |
| 5Y | $928.39M | +78.9% | |
| All | $437.50M | +279.7% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of RPRX?
As of today, RPRX TTM EBITDA is $1.66B
What is RPRX TTM EBITDA most recent change?
RPRX TTM EBITDA was up +6.37% on March 31, 2026
What is 1-year change in RPRX TTM EBITDA?
RPRX TTM EBITDA is down -12.57% year-over-year
How far is RPRX TTM EBITDA from its all-time high?
RPRX TTM EBITDA is currently -37.51% below its historical high of $2.66B set on June 30, 2020
How does RPRX TTM EBITDA rank versus sector peers?
RPRX TTM EBITDA is higher than 95.01% of companies in Healthcare sector
When is RPRX next earnings release?
The next earnings release for RPRX is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- RPRX Official Website www.royaltypharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1802768/000180276826000003/0001802768-26-000003-index.htm
- RPRX Profile on Yahoo Finance finance.yahoo.com/quote/RPRX
- RPRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rprx